Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute bacterial meningitis

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical meningeal infection

Fever, headache, neck stiffness, altered cognition, seizure, focal deficit or a non-blanching rash can represent bacterial meningitis and irreversible injury accumulates while treatment waits.

Action: Use ABCDE, obtain blood cultures and PCR, give dexamethasone with or immediately before meningitis-dose ceftriaxone, and add amoxicillin when Listeria risk applies. Perform lumbar puncture promptly only when safe; CT must not become a routine delay.

Synopsis

Recognise bacterial meningitis without relying on a complete triad, obtain blood and cerebrospinal-fluid evidence safely, and give ceftriaxone, dexamethasone and Listeria cover in the correct sequence.

  • The classic fever, neck stiffness and altered-consciousness triad is insensitive; severe headache or cognitive change with fever warrants urgent evaluation.
  • Take blood cultures and EDTA blood for meningococcal and pneumococcal PCR before antibiotics only when this causes no delay.
  • Give ceftriaxone 2 g intravenously every 12 hours in adults with suspected bacterial meningitis.
  • Give dexamethasone 10 mg intravenously every 6 hours for 4 days, starting with or immediately before the first antibiotic and reviewing when the organism is known.
  • Add amoxicillin 2 g intravenously every 4 hours for people with Listeria risk under NICE and local renal guidance.
  • Lumbar puncture is the key diagnostic test when safe; do not perform it during shock, uncontrolled seizure or clinical evidence of mass effect.
  • Use CT before lumbar puncture only for specified neurological risks, not because meningitis is suspected in every patient.
  • Notify relevant disease, provide meningococcal contact prevention and arrange hearing and neurocognitive follow-up after survival.

Key red flags

Altered consciousness, shock, focal neurology, papilloedema or uncontrolled seizure changes lumbar-puncture safety and requires senior escalation.

A rapidly spreading non-blanching rash or severe limb pain raises meningococcal septicaemia and needs immediate sepsis care.

Older age, pregnancy or immune suppression increases Listeria risk and requires amoxicillin in addition to ceftriaxone.

Antibiotics already given do not remove the need for lumbar puncture once safe because PCR and CSF pattern remain valuable.

Meningeal syndrome

Fever, severe headache, neck stiffness, photophobia, vomiting and altered cognition creates a high-probability syndrome even when one feature is absent.

Meningococcal sepsis

Purpura, mottling, severe limb pain and shock suggests concurrent bloodstream disease requiring critical care.

Raised intracranial pressure

Falling consciousness, focal deficit, papilloedema, abnormal pupils or repeated seizure indicates mass effect and changes lumbar-puncture safety.

Listeria context

Older age, pregnancy, malignancy, transplant or major immune suppression increases L monocytogenes probability despite absence of a distinctive rash.

Investigation priorities

01
Blood cultures and blood PCRFirst step

Identify bacteria without requiring lumbar puncture safety.

Management branches

ASSESSTreat before diagnostic delay

Bacterial meningitis is clinically suspected in an adult.

  1. Use ABCDE, glucose and early senior review; take blood cultures and PCR and start therapy immediately when sampling would delay.
  2. Give dexamethasone with or immediately before ceftriaxone and add amoxicillin when Listeria risk exists.
  3. Treat seizure, shock, hypoglycaemia, hypoxia and raised intracranial pressure with critical-care and neurological support.
  4. Notify suspected meningococcal disease and use appropriate droplet precautions until the public-health and treatment criteria are met.
TREATObtain safe microbiological evidence

The patient is stable enough for lumbar puncture or testing can continue after initial treatment.

  1. Assess lumbar-puncture contraindications clinically and perform puncture promptly without routine CT when safe.
  2. Record opening pressure and send sufficient labelled CSF for microscopy, culture, bacterial PCR and exposure-directed viral or TB testing.
  3. If puncture was initially unsafe, reassess after stabilisation; prior ceftriaxone does not make later CSF worthless.
  4. Investigate ear, sinus, skull-base, endocardial or device sources when organism or course suggests contiguous or persistent seeding.

Key medicines

Ceftriaxone empirical meningitis treatmentGive ceftriaxone 2 g intravenously every 12 hours in adults with suspected bacterial meningitis.Check immediate cephalosporin allergy and local resistance, obtain cultures when safe and never delay for CT or lumbar puncture.
Dexamethasone adjunctGive dexamethasone 10 mg intravenously every 6 hours for 4 days, starting with or immediately before the first antibiotic.Review glucose, gastrointestinal bleeding and organism; late initiation has less evidence and continuation depends on the confirmed cause.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG240 meningitis recommendationsCurrent UK adult assessment, ceftriaxone, amoxicillin, dexamethasone and lumbar-puncture sequencing.
  • UKHSA meningococcal disease guidance collectionPCR, notification, contact prevention and laboratory support.
  • NHS meningitisPublic symptom and emergency recognition advice.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom